WallStreetZenWallStreetZen

NASDAQ: REPL
Replimune Group Inc Stock Ownership - Who owns Replimune Group?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Replimune Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Emily Luisa HillCFO2026-08-179,256$14.28
$132.18kSell
Andrew SchwendenmanCAO2026-08-107,632$12.97
$98.99kSell
Sushil PatelCEO2026-08-1039,341$12.97
$510.25kSell
Konstantinos XynosMed2026-08-1011,447$12.97
$148.47kSell
Emily Luisa HillCFO2026-08-1011,448$12.97
$148.48kSell
Christopher SarchiChief Commercial Officer2026-06-0112,000$9.24
$110.88kSell
Philip AstleysparkeDirector2026-05-1817,657$5.08
$89.70kSell
Emily Luisa HillChief Financial Officer2026-05-187,812$5.08
$39.68kSell
Sushil PatelChief Executive Officer2026-05-1837,324$5.08
$189.61kSell
Christopher SarchiChief Commercial Officer2026-05-188,626$5.08
$43.82kSell

1 of 2

REPL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REPL insiders and whales buy or sell their stock.

REPL Shareholders

What type of owners hold Replimune Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP10.74%10,116,095$149.41MInsider
Omega Fund IV LP10.02%9,436,760$139.38MInsider
Hugo Alexander Slootweg5.01%4,721,449$69.74MInsider
Forbion Capital Fund III Cooperatief Ua5.01%4,721,449$69.74MInsider
Bain Capital Life Sciences Investors LLC3.01%2,838,968$41.93MInsider
Atlas Venture Fund X LP2.64%2,486,296$36.72MInsider
Robert Coffin1.93%1,821,872$26.91MInsider
Philip Astleysparke1.45%1,362,414$20.12MInsider
Atlas Venture Opportunity Fund I LP1.17%1,100,000$16.25MInsider
Redmile Group LLC0.83%779,655$11.52MInsider

1 of 3

REPL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REPL0.10%44.82%Net SellingNet Selling
MAZE0.11%11.19%Net SellingNet Selling
CGEM0.11%76.11%Net BuyingNet Buying
VOR0.08%29.13%Net SellingNet Buying
AKTS0.06%57.57%Net BuyingNet Buying
View Top Biotech Stocks

Replimune Group Stock Ownership FAQ

Who owns Replimune Group?

Replimune Group (NASDAQ: REPL) is owned by 0.10% institutional shareholders, 44.82% Replimune Group insiders, and 55.08% retail investors. Baker Bros Advisors LP is the largest individual Replimune Group shareholder, owning 10.12M shares representing 10.74% of the company. Baker Bros Advisors LP's Replimune Group shares are currently valued at $146.18M.

If you're new to stock investing, here's how to buy Replimune Group stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.